Mulder T P, Verspaget H W, Sier C F, Roelofs H M, Ganesh S, Griffioen G, Peters W H
Department of Gastroenterology, St. Radboud University Hospital, Nijmegen, The Netherlands.
Cancer Res. 1995 Jun 15;55(12):2696-702.
Glutathione S-transferases (GSTs) are enzymes involved in the detoxification of xenobiotics and are divided into four subclasses, alpha, mu, pi, and theta, with different although overlapping substrate specificities. Most human gastrointestinal tumors contain increased amounts of GST-pi and GST enzyme activity. The relationship between GST parameters and tumor and patient characteristics, including overall survival, were studied retrospectively in 100 primary colorectal adenocarcinomas. Levels of GST-alpha, GST-mu, GST-pi, and GST enzyme activity were not related to the Dukes stage, differentiation grade, localization, histological type and diameter of the tumor, or gender and age of the patient. Fifty-seven patients died (median survival, 21 months; range, 1-65 months) during follow-up, and 43 patients were still alive at the closing date of the study (median follow-up, 68 months; range, 60-87 months). Optimal dichotomization and uni- and multivariate analyses were done with the Cox proportional hazard model. Multivariate analysis with all clinicopathological parameters revealed higher Dukes stage (hazard ratio, 2.7; P < 0.001) and older age (hazard ratio, 2.8; P = 0.001) to be the only independent prognostic variables for overall survival. In contrast to GST-alpha and GST-mu, high levels of GST-pi (hazard ratio, 3.1; P = 0.002) and GST enzyme activity (hazard ratio, 2.0; P = 0.020) in the tumors were found to have a significant prognostic value independent from the clinicopathological parameters when added separately to this Cox model. Thus, this study indicates that GST subclass levels in colorectal adenocarcinomas are not related to clinicopathological parameters and that the GST-pi level and GST enzyme activity have a prognostic value for the overall survival of the patients.
谷胱甘肽S-转移酶(GSTs)是参与外源性物质解毒的酶,分为四个亚类,即α、μ、π和θ,它们的底物特异性虽有不同但相互重叠。大多数人类胃肠道肿瘤中谷胱甘肽S-转移酶π(GST-π)含量增加且GST酶活性增强。本研究对100例原发性结肠腺癌患者进行回顾性分析,探讨GST参数与肿瘤及患者特征(包括总生存期)之间的关系。GST-α、GST-μ、GST-π水平及GST酶活性与肿瘤的Dukes分期、分化程度、位置、组织学类型、直径,以及患者的性别和年龄均无关。随访期间,57例患者死亡(中位生存期21个月;范围1 - 65个月),43例患者在研究截止日期时仍存活(中位随访时间68个月;范围60 - 87个月)。采用Cox比例风险模型进行最佳二分法以及单因素和多因素分析。对所有临床病理参数进行多因素分析显示,较高的Dukes分期(风险比,2.7;P < 0.001)和较高年龄(风险比,2.8;P = 0.001)是总生存期的唯一独立预后变量。与GST-α和GST-μ不同,当分别将肿瘤中高水平的GST-π(风险比,3.1;P = 0.002)和GST酶活性(风险比,2.0;P = 0.020)添加到该Cox模型中时,发现它们具有独立于临床病理参数的显著预后价值。因此,本研究表明结肠腺癌中的GST亚类水平与临床病理参数无关,而GST-π水平和GST酶活性对患者的总生存期具有预后价值。